Tech Company Inital Public Offerings
Lava Therapeutics IPO
Lava Therapeutics was bought by . The company's stock became public on 3/25/2021.
Transaction Overview
Company Name
Announced On
3/25/2021
Transaction Type
IPO
Amount
$100,500,000
Proceeds Purpose
Use of proceeds for the LAVA Therapeutics IPO are outlined in the company's S1 filing.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
Yalelaan 60
Utrecht, 3584 CM
The Netherlands
Utrecht, 3584 CM
The Netherlands
Phone
Website
Email Address
Overview
Lava Therapeutics B.V. is a start-up biotechnology company, founded in 2016, that creates and develops next generation ?d T-cell engaging bispecific antibodies for the treatment of cancer. Our first-in-class immuno-oncology approach activates ?d T cells in a tumor target dependent manner.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Steve Hurly
Chief Marketing Officer
Benjamin Winograd
Chief Scientific Officer
Hans van der Vliet
VP - Bus. Development
Ton Adang
VP - R & D
Paul Parren
Browse more venture capital transactions:
Prev: 3/25/2021: Blockchain venture capital transaction
Next: 3/25/2021: HiDef venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs